1 of 5000

|

canvas prints car canvas prints abnormal canvas prints liver cancer canvas prints cancer cell canvas prints cancerous canvas prints cell canvas prints biology canvas prints coloured canvas prints disease canvas prints false-coloured canvas prints growth canvas prints histopathological canvas prints histopathology canvas prints malignancy canvas prints malignant canvas prints

photographs car photos abnormal photos liver cancer photos cancer cell photos cancerous photos cell photos biology photos coloured photos disease photos false-coloured photos growth photos histopathological photos histopathology photos malignancy photos malignant photos

Add This Artwork to Your Favorites Collection

Comment

Add This Artwork to Your Favorites Collection

Comment

T-cells and lung cancer cell. Composite coloured scanning electron micrograph (SEM) of T-cells and an mesothelioma lung cancer cell. T-cells are a component of the body's immune system. CAR T-cell therapy takes T-cells from a cancer patient's blood and modifies them to recognize a specific protein found on patient's tumor cells. When reintroduced to the patient the T-cells find and destroy the tumour cells. The newest form of CAR T-cell therapy, now in clinical trials, uses 'memory' T-cells which remain in the body after attacking the cancer. The hope is that memory T-cells may provide an active reservoir of cancer-killing cells capable of stopping further tumours. Magnification: x3000 at 10cm wide. Specimen courtesy of Professor Greg Towers, University College London, UK

Science Photo Library (SPL) is the leading source of science images and footage. Sourced from scientific and medical experts, acclaimed photographers and renowned institutions, our content is unrivaled worldwide. Outstanding quality, accuracy and commitment to excellence are deeply embedded in our DNA. Science Photo Library inspires creative professionals and delivers engaging content of the highest quality for a wide range of clients in a variety of sectors. Visit sciencephoto.com for more information and stay connected on Twitter, LinkedIn, Instagram and Vimeo.